0.00
100.00%
-0.661
Acorda Therapeutics Inc Azioni (ACOR) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 |
Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
Revenues |
6.60%
27.71
|
29.68 | 22.26 | 31.47 | 33.51 |
Cost Of Revenue |
10.51%
3.387
|
3.065 | 3.234 | 4.56 | 11.01 |
Gross Profit |
8.58%
24.33
|
26.61 | 19.02 | 26.91 | 22.51 |
Operating Expenses
|
11.23%
26.85
|
30.24 | 30.50 | 26.64 | 27.50 |
Interest Income/Expense |
2.71%
7.984
|
7.773 | 7.571 | 7.699 | 7.465 |
Benefits Costs and Expenses |
8.20%
37.66
|
41.02 | 41.12 | 9.896 | 45.95 |
Costs And Expenses |
9.23%
30.23
|
33.31 | 33.73 | 31.20 | 38.50 |
Operating Income/Loss |
30.64%
-2.519
|
-3.632 | -11.48 | 0.267 | -4.989 |
Nonoperating Income/Loss |
3.76%
-7.424
|
-7.714 | -7.386 | 21.31 | -7.449 |
Income/Loss From Continuing Operations Before Tax |
12.37%
-9.943
|
-11.35 | -18.86 | 21.57 | -12.44 |
Income Tax Expense/Benefit, Deferred |
48.19%
-1.018
|
-1.965 | -2.038 | 2.369 | - |
Income Tax Expense/Benefit |
46.31%
-1.055
|
-1.965 | -2.038 | 2.432 | 1.416 |
Income/Loss From Continuing Operations After Tax |
5.26%
-8.888
|
-9.381 | -16.82 | 19.14 | -13.85 |
Net Income/Loss
|
5.26%
-8.888
|
-9.381 | -16.82 | 19.14 | -13.85 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
0.00%
1.242
|
1.242 | 24.34 | 1.559 | 24.29 |
Diluted Average Shares |
0.00%
1.242
|
1.242 | 24.34 | 1.559 | 24.29 |
Basic Earnings Per Share |
5.17%
-7.16
|
-7.55 | -0.69 | 1.35 | -0.57 |
Diluted Earnings Per Share |
5.17%
-7.16
|
-7.55 | -0.69 | 1.35 | -0.57 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Capitalizzazione:
|
Volume (24 ore):